ADBIOTECH Co.,Ltd. Logo

ADBIOTECH Co.,Ltd.

Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.

179530 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
강원도 춘천시 동내면 거두단지1길 39, 춘천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and sale of next-generation immune antibodies. The company's core technology is based on Immunoglobulin Y (IgY), producing specific antibodies from eggs as alternatives to conventional vaccines and antibiotics. Its product portfolio serves diverse markets, including livestock, aquaculture, and human health, with commercialized products sold both domestically and internationally. ADBIOTECH is actively expanding its R&D pipeline to include human therapies, such as Helico IgY and Cholesterol IgY, and is entering the global companion animal market with its proprietary VHH (nanobody) technology. The company manages the entire value chain from research to production and sales, positioning itself as a leader in the IgY technology field.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ADBIOTECH Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 31.7 KB
2025-09-15 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 133.2 KB
2025-09-15 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 81.3 KB

Automate Your Workflow. Get a real-time feed of all ADBIOTECH Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ADBIOTECH Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea 106190

Talk to a Data Expert

Have a question? We'll get back to you promptly.